Computerized vision testing systems manufacturer M&S Technologies recently announced the Glare Testing unit for its Clinical Trial Suite (CTS) complies with the ANSI standard by decreasing contrast sensitivity function by 0.1 log units across several spatial frequencies, and its CTS now interfaces with the M&S DataRight module.
M&S Technologies' Clinical Trial Suite features a variety of visual acuity and contrast sensitivity protocols that can be customized to specifically meet the sponsors' trial needs. According to M&S, the glare testing option can be helpful for clinical trial sponsors to want to use how a new product impacts patients' vision under glare conditions. And the CTS Glare Testing unit operates seamlessly with any software module available in the CTS system, including contrast sensitivity testing under mesopic luminance conditions.
Click here to read the full press release.
And CTS now interfaces with M&S' DataRight module, which makes it possible to fully retrieve raw data and test results for intermediate review and analysis by the plan sponsor or lead investigator. Additionally, DataRight’s encrypted transfer ensures the security of any clinical trial information.
Click here to read the full press release.